C17ORF85 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.084400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.200400E-01
Normal-vs-Stage2
5.269700E-02
Normal-vs-Stage3
4.680500E-03
Normal-vs-Stage4
3.350600E-01
Stage1-vs-Stage2
6.981600E-01
Stage1-vs-Stage3
8.117700E-02
Stage1-vs-Stage4
7.748000E-01
Stage2-vs-Stage3
5.029700E-02
Stage2-vs-Stage4
4.696800E-01
Stage3-vs-Stage4
4.676200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.705900E-02
Normal-vs-AfricanAmerican
1.948430E-01
Normal-vs-Asian
5.080400E-02
Caucasian-vs-AfricanAmerican
6.460000E-01
Caucasian-vs-Asian
2.466400E-01
AfricanAmerican-vs-Asian
2.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.928500E-02
Normal-vs-Female
9.828200E-02
Male-vs-Female
4.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.090180E-01
Normal-vs-Age(41-60Yrs)
2.378400E-01
Normal-vs-Age(61-80Yrs)
2.899700E-02
Normal-vs-Age(81-100Yrs)
1.424800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.079000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.122800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.990600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.422000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.464590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.349500E-02
Normal-vs-Daily Drinker
2.002500E-02
Normal-vs-Weekly Drinker
7.608100E-02
Normal-vs-Occasional Drinker
2.720800E-01
Normal-vs-Social Drinker
3.480000E-01
Non Drinker-vs-Daily Drinker
9.367400E-01
Non Drinker-vs-Weekly Drinker
4.864000E-01
Non Drinker-vs-Occasional Drinker
1.167170E-01
Non Drinker-vs-Social Drinker
4.623900E-02
Daily Drinker-vs-Weekly Drinker
4.568800E-01
Daily Drinker-vs-Occasional Drinker
1.244580E-01
Daily Drinker-vs-Social Drinker
5.028300E-02
Weekly Drinker-vs-Occasional Drinker
4.690400E-01
Weekly Drinker-vs-Social Drinker
2.662600E-01
Occasional Drinker-vs-Social Drinker
7.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.219600E-01
Normal-vs-Grade 2
7.964600E-01
Normal-vs-Grade 3
7.806400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.599800E-01
Grade 1-vs-Grade 3
6.032000E-01
Grade 1-vs-Grade 4
4.219600E-01
Grade 2-vs-Grade 3
7.505600E-01
Grade 2-vs-Grade 4
7.964600E-01
Grade 3-vs-Grade 4
7.806400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.860060E-02
Normal-vs-NonDiabetic
6.721600E-02
Diabetic-vs-NonDiabetic
2.082400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.748300E-02
Normal-vs-NoPancreatitis
6.029900E-02
Pancreatitis-vs-NoPancreatitis
7.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.455610E-01
Normal-vs-N1
4.894500E-02
N0-vs-N1
4.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.859870E-02
Normal-vs-TP53-NonMutant
2.135800E-01
TP53-Mutant-vs-TP53-NonMutant
1.433690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
